Seeking Alpha

Jefferies starts Verastem at Buy

  • Verastem (VSTM +1.7%) is initiated with a Buy rating at Jefferies. Price target is $21, representing a 42% upside from Friday's close.
  • Analyst Biren Amin says VS-6063 "has favorable odds of showing a PFS benefit [in mesothelioma trials], supporting potential accelerated approval in H2 2016."
  •  For more on VS-6063, see previous coverage.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio: